Evidence map›Paper›PMID 35588113›Full record

ArticlePloS one2022

Predictors of Hepatitis B screening and vaccination status of young psychoactive substance users in informal settlements in Kampala, Uganda.

Tonny Ssekamatte, John Bosco Isunju, Joan Nankya Mutyoba, Moses Tetui, Richard K Mugambe, Aisha Nalugya, Winnifred K Kansiime, Chenai Kitchen, Wagaba Brenda, Patience Oputan and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Tonny SsekamatteDepartment of Disease Control and Environmental Health, Makerere University School of Public Health, Kampala, Uganda.ORCID 0000-0002-8127-6759
John Bosco IsunjuDepartment of Disease Control and Environmental Health, Makerere University School of Public Health, Kampala, Uganda.
Joan Nankya MutyobaDepartment of Epidemiology and Biostatistics, Makerere University School of Public Health, Kampala, Uganda.
Moses TetuiDepartment of Health Policy Planning and Management, Makerere University School of Public Health, Kampala, Uganda.
Richard K MugambeDepartment of Disease Control and Environmental Health, Makerere University School of Public Health, Kampala, Uganda.ORCID 0000-0003-2311-5436
Aisha NalugyaDepartment of Disease Control and Environmental Health, Makerere University School of Public Health, Kampala, Uganda.
Winnifred K KansiimeDepartment of Disease Control and Environmental Health, Makerere University School of Public Health, Kampala, Uganda.
Chenai KitchenDepartment of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi'an Jiaotong University, Xi'an, China.
Wagaba BrendaDepartment of Disease Control and Environmental Health, Makerere University School of Public Health, Kampala, Uganda.
Patience OputanDepartment of Disease Control and Environmental Health, Makerere University School of Public Health, Kampala, Uganda.
Justine Nnakate BukenyaDepartment of Community Health and Behavioural Sciences, Makerere University School of Public Health, Kampala, Uganda.
Esther BuregyeyaDepartment of Disease Control and Environmental Health, Makerere University School of Public Health, Kampala, Uganda.
Simon P S KibiraDepartment of Community Health and Behavioural Sciences, Makerere University School of Public Health, Kampala, Uganda.
Makerere University · UGXi'an Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundYoung psychoactive substance users exhibit high-risk behaviours such as unprotected sexual intercourse, and sharing needles and syringes, which increases their risk of Hepatitis B infection. However, there is limited evidence of screening, and vaccination status of this subgroup. The aim of this study was to establish the predictors of screening and completion of the hepatitis B vaccination schedule.

methodsA cross-sectional study using respondent driven sampling was used to enrol respondents from twelve out of fifty-seven informal settlements in Kampala city. Data were collected using an electronic structured questionnaire uploaded on the KoboCollect mobile application, and analysed using Stata version 14. A "modified" Poisson regression analysis was done to determine the predictors of screening while logistic regression was used to determine the predictors of completion of the Hepatitis B vaccination schedule.

resultsAbout 13.3% (102/768) and 2.7% (21/768) of the respondents had ever screened for Hepatitis B, and completed the Hepatitis B vaccination schedule respectively. Being female (aPR 1.61, 95% CI: 1.11-2.33), earning a monthly income >USD 136 (aPR 1.78, 95% CI: 1.11-2.86); completion of the Hepatitis B vaccination schedule (aPR 1.85, 95% CI: 1.26-2.70); lack of awareness about the recommended Hepatitis B vaccine dose (aPR 0.43, 95% CI: 0.27-0.68); and the belief that the Hepatitis B vaccine is effective in preventing Hepatitis B infection (aPRR 3.67, 95% CI: 2.34-5.73) were associated with "ever screening" for Hepatitis B. Knowledge of the recommended Hepatitis B vaccine dose (aOR 0.06, 95% CI: 0.01-0.35); "ever screening" for hepatitis B (aOR 9.68, 95% CI: 2.17-43.16) and the belief that the hepatitis B vaccine is effective in preventing Hepatitis B infection (aOR 11.8, 95% CI: 1.13-110.14) were associated with completion of the hepatitis B vaccination schedule.

conclusionsOur findings indicate a low prevalence of Hepatitis B screening and completion of the Hepatitis B vaccination schedule among young psychoactive substance users in informal settings. It is evident that lack of awareness about Hepatitis B is associated with the low screening and vaccination rates. We recommend creation of awareness of Hepatitis B among young people in urban informal settlements.

Indexed as

Hepatitis BHepatitis B VaccinesAdolescentCross-Sectional StudiesFemaleHumansMaleUgandaVaccinationHepatitis B Vaccines

Identifiers

PMID35588113
PMCPMC9119510
OpenAlexW4280610853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.